rs786204101
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.2900_2901insC(p.Pro968AlafsTer151) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P967P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
KCNH2
NM_000238.4 frameshift
NM_000238.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.509
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-150947670-C-CG is Pathogenic according to our data. Variant chr7-150947670-C-CG is described in ClinVar as [Pathogenic]. Clinvar id is 188144.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2900_2901insC | p.Pro968AlafsTer151 | frameshift_variant | 12/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.2900_2901insC | p.Pro968AlafsTer151 | frameshift_variant | 12/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 | |
KCNH2 | ENST00000330883.9 | c.1880_1881insC | p.Pro628AlafsTer151 | frameshift_variant | 8/11 | 1 | ENSP00000328531 | |||
KCNH2 | ENST00000684241.1 | n.3733_3734insC | non_coding_transcript_exon_variant | 10/13 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 36
GnomAD4 exome
Cov.:
36
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1
Pathogenic, no assertion criteria provided | research | deCODE genetics, Amgen | Jul 21, 2023 | The variant NM_000238.4:c.2900dup (chr7:150947670) in KCNH2 was detected in 8 heterozygotes out of 58K WGS Icelanders (MAF= 0,007%). Following imputation in a set of 166K Icelanders (20 imputed heterozygotes) we observed an association with an elongation of the qt interval on ECG using measurements from 80068 individuals (Effect (SD)= 1.18, P= 3.38e-03). This variant has been reported in ClinVar previously as pathogenic. Based on ACMG criteria (PVS1, PS4, PP5) this variant classifies as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2016 | The c.2900dupC pathogenic variant in the KCNH2 gene has been reported previously in association with LQTS (Berge et al., 2008; Seethala et al., 2015). The c.2900dupC varaint causes a shift in reading frame starting at codon Proline 968, changing it to an Alanine, and creating a premature stop codon at position 151 of the new reading frame, denoted p.Pro968AlafsX151. This pathogenic variant is expected to result in an abnormal protein product. Other frameshift variants in the KCNH2 gene have been reported in HGMD in association with LQTS (Stenson et al., 2014). Furthermore, the c.2900dupC variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project (average read depth 9.0). - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 25, 2015 | This sequence change has been reported in one individual affected with long QT syndrome (PMID: 18752142) and is not present in population databases. This sequence change duplicates a C nucleotide in exon 12 of the KCNH2 mRNA (c.2900dupC), causing a frameshift at codon 968. This creates a premature translational stop signal (p.Pro968Alafs*151) and is expected to result in an absent or truncated protein product. Truncating sequence changes in KCNH2 are known to be pathogenic (PMID: 10973849, 17576861). In summary, this is a truncating sequence change  which is not reported in population databases, and has been observed in in one individual affected with long QT. For these reasons, this sequence change has been classified as Pathogenic - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at